Login / Signup

Retreatment with full-dose cytarabine in a patient with previous neurological toxicity.

Núria Meca CasasnovasAlba ManzanequeAna MuntañolaGenís Castells Lao
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
This original case report assesses the possibility of retreatment without the need for dose reduction.
Keyphrases
  • case report
  • acute myeloid leukemia
  • high dose
  • oxidative stress
  • low dose